Literature DB >> 31235644

Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.

Atsuko Kubo1, Shouyou Ueda1, Ayaka Yamane2, Satoko Wada-Kakuda1, Mai Narita1, Makoto Matsuyama3, Akane Nomori3, Akihiko Takashima4,5, Taisuke Kato6, Osamu Onodera6, Motohito Goto7, Mamoru Ito7, Takami Tomiyama8, Hiroshi Mori8, Shigeo Murayama9, Yasuo Ihara1, Hiroaki Misonou2,5, Tomohiro Miyasaka10,5.   

Abstract

Tau is a microtubule (MT)-associated protein that is localized to the axon. In Alzheimer's disease, the distribution of tau undergoes a remarkable alteration, leading to the formation of tau inclusions in the somatodendritic compartment. To investigate how this mislocalization occurs, we recently developed immunohistochemical tools that can separately detect endogenous mouse and exogenous human tau with high sensitivity, which allows us to visualize not only the pathological but also the pre-aggregated tau in mouse brain tissues of both sexes. Using these antibodies, we found that in tau-transgenic mouse brains, exogenous human tau was abundant in dendrites and somata even in the presymptomatic period, whereas the axonal localization of endogenous mouse tau was unaffected. In stark contrast, exogenous tau was properly localized to the axon in human tau knock-in mice. We tracked this difference to the temporal expression patterns of tau. Endogenous mouse tau and exogenous human tau in human tau knock-in mice exhibited high expression levels during the neonatal period and strong suppression into the adulthood. However, human tau in transgenic mice was expressed continuously and at high levels in adult animals. These results indicated the uncontrolled expression of exogenous tau beyond the developmental period as a cause of mislocalization in the transgenic mice. Superresolution microscopic and biochemical analyses also indicated that the interaction between MTs and exogenous tau was impaired only in the tau-transgenic mice, but not in knock-in mice. Thus, the ectopic expression of tau may be critical for its somatodendritic mislocalization, a key step of the tauopathy.SIGNIFICANCE STATEMENT Somatodendritic localization of tau may be an early step leading to the neuronal degeneration in tauopathies. However, the mechanisms of the normal axonal distribution of tau and the mislocalization of pathological tau remain obscure. Our immunohistochemical and biochemical analyses demonstrated that the endogenous mouse tau is transiently expressed in neonatal brains, that exogenous human tau expressed corresponding to such tau expression profile can distribute into the axon, and that the constitutive expression of tau into adulthood (e.g., human tau in transgenic mice) results in abnormal somatodendritic localization. Thus, the expression profile of tau is tightly associated with the localization of tau, and the ectopic expression of tau in matured neurons may be involved in the pathogenesis of tauopathy.
Copyright © 2019 the authors.

Entities:  

Keywords:  Alzheimer; axon; tau; tauopathy

Mesh:

Substances:

Year:  2019        PMID: 31235644      PMCID: PMC6703881          DOI: 10.1523/JNEUROSCI.2845-18.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Authors:  N Matsumura; T Yamazaki; Y Ihara
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.

Authors:  E Planel; K Yasutake; S C Fujita; K Ishiguro
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

3.  A primary culture system for biochemical analyses of neuronal proteins.

Authors:  Hiroaki Misonou; James S Trimmer
Journal:  J Neurosci Methods       Date:  2004-12-18       Impact factor: 2.390

4.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

Authors:  A Delacourte; J P David; N Sergeant; L Buée; A Wattez; P Vermersch; F Ghozali; C Fallet-Bianco; F Pasquier; F Lebert; H Petit; C Di Menza
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

5.  Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.

Authors:  J Götz; F Chen; J van Dorpe; R M Nitsch
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

6.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

7.  Tau protein in normal and Alzheimer's disease brain.

Authors:  G V Johnson; S M Jenkins
Journal:  J Alzheimers Dis       Date:  1999-11       Impact factor: 4.472

8.  C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease.

Authors:  A Abraha; N Ghoshal; T C Gamblin; V Cryns; R W Berry; J Kuret; L I Binder
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

9.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

Authors:  H N Dawson; A Ferreira; M V Eyster; N Ghoshal; L I Binder; M P Vitek
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

10.  Repeat motifs of tau bind to the insides of microtubules in the absence of taxol.

Authors:  Santwana Kar; Juan Fan; Michael J Smith; Michel Goedert; Linda A Amos
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

View more
  4 in total

1.  Neuronal and Glial Distribution of Tau Protein in the Adult Rat and Monkey.

Authors:  Nicholas M Kanaan; Tessa Grabinski
Journal:  Front Mol Neurosci       Date:  2021-04-27       Impact factor: 5.639

2.  Regulatory mechanisms for the axonal localization of tau protein in neurons.

Authors:  Minori Iwata; Shoji Watanabe; Ayaka Yamane; Tomohiro Miyasaka; Hiroaki Misonou
Journal:  Mol Biol Cell       Date:  2019-08-07       Impact factor: 4.138

Review 3.  Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects.

Authors:  Hadeel Alyenbaawi; W Ted Allison; Sue-Ann Mok
Journal:  Biomolecules       Date:  2020-10-27

4.  Disulfide bond formation in microtubule-associated tau protein promotes tau accumulation and toxicity in vivo.

Authors:  Taro Saito; Tomoki Chiku; Mikiko Oka; Satoko Wada-Kakuda; Mika Nobuhara; Toshiya Oba; Kanako Shinno; Saori Abe; Akiko Asada; Akio Sumioka; Akihiko Takashima; Tomohiro Miyasaka; Kanae Ando
Journal:  Hum Mol Genet       Date:  2021-10-13       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.